Kuala Lumpur, Malaysia – April 5-6, 2025 – RGCC was honored to take part in a landmark international conference in Kuala Lumpur, which marked the official launch of the International Society for Personalized Metabolic Oncology (ISPMO). The two-day event brought together approximately 75 medical and integrative practitioners from across Southeast Asia to engage in focused discussions on the clinical advancement of personalized metabolic oncology.
Hosted in the heart of Malaysia’s capital, the conference featured a robust program of keynote sessions and expert-led workshops dedicated to sharing scientific knowledge and clinical best practices in the evolving landscape of integrative cancer care.
Dr. Ioannis Papasotiriou, Director and CEO of RGCC International, joined a distinguished lineup of speakers, including Dr. John Soo, Dr. Sarah Khong, and a panel of experienced integrative doctors and oncologists from the region.
Highlights of the conference included:
- Oncotrace Explained: Science, Sensitivity, and Proper Clinical Use presented by Dr. Ioannis Papasotiriou
- Integrative Cancer Workshop with Dr. Ioannis Papasotiriou, Dr John Soo, and Dr Sarah Khong
- What is an RGCC Remission? Cancer Patient Management, How to Monitor, When to Intervene by Dr. Jervin Lim
The event concluded with a networking session, providing a valuable forum for practitioners and thought leaders to exchange insights, foster collaborations, and explore new avenues for patient-centered care.
The launch of ISPMO represents a promising step forward in building an international, multidisciplinary community dedicated to advancing personalized, science-led approaches to cancer treatment. RGCC remains committed to contributing to this global movement through continued innovation, research, and collaboration.